CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,359,736
- in 11 filings, $2.4M under 10b5-1 plans
Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −5,498 | $60.33 | $332K | 36,092 |
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −10,800 | $61.64 | $666K | 25,292 |
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −11,954 | $62.25 | $744K | 13,338 |
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Sale | −400 | $63.07 | $25K | 12,938 |
| 2018-03-01 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Exercise or conversion · Stock Option | −18,750 | 6,250 | ||
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion | +9,375 | $40.59 | $381K | 219,358 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion | +6,375 | $33.00 | $210K | 225,733 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion | +8,236 | $6.36 | $52K | 233,969 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Sale | −11,326 | $60.59 | $686K | 222,643 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Sale | −8,400 | $61.62 | $518K | 214,243 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Sale | −4,260 | $62.17 | $265K | 209,983 |
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Option | −9,375 | 28,125 | ||
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Option | −6,375 | 6,375 | ||
| 2018-03-01 | PRZYBYL ARTHUR President and CEO | Exercise or conversion · Stock Option | −8,236 | 15,723 | ||
| 2017-05-22 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −450 | $47.01 | $21K | 22,840 |
| 2017-05-22 | Marken James G. SVP Ops & Prod Dev | Shares withheld for taxes | −278 | $47.01 | $13K | 51,549 |
| 2017-05-22 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −991 | $47.01 | $47K | 210,833 |
| 2017-04-17 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −1,161 | $51.22 | $59K | 211,824 |
| 2017-04-17 | Schrepfer Robert W SVP - New Bus Dev & Spec Sales | Shares withheld for taxes | −270 | $51.22 | $14K | 23,290 |
| 2017-04-07 | PRZYBYL ARTHUR President and CEO | Shares withheld for taxes | −1,451 | $51.24 | $74K | 212,985 |
Page 34 of 41 · 804 trades